| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Valve Prosthesis Implantation | 4 | 2019 | 452 | 1.670 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2020 | 127 | 1.360 |
Why?
|
| Heart Defects, Congenital | 15 | 2024 | 1874 | 1.210 |
Why?
|
| Heart Valve Prosthesis | 3 | 2023 | 309 | 1.080 |
Why?
|
| Pulmonary Valve | 2 | 2019 | 96 | 1.070 |
Why?
|
| Angioplasty, Balloon | 3 | 2017 | 162 | 1.060 |
Why?
|
| Cardiac Catheterization | 8 | 2023 | 662 | 0.930 |
Why?
|
| Mustard Plant | 1 | 2022 | 4 | 0.810 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 5 | 0.810 |
Why?
|
| Treatment Outcome | 22 | 2024 | 13011 | 0.810 |
Why?
|
| Stents | 6 | 2020 | 877 | 0.770 |
Why?
|
| Pulmonary Artery | 4 | 2023 | 455 | 0.750 |
Why?
|
| Septal Occluder Device | 2 | 2019 | 45 | 0.700 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 1093 | 0.700 |
Why?
|
| Aortic Valve | 3 | 2019 | 457 | 0.660 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 206 | 0.630 |
Why?
|
| Stenosis, Pulmonary Artery | 1 | 2019 | 6 | 0.620 |
Why?
|
| Dyspnea | 1 | 2020 | 160 | 0.620 |
Why?
|
| Aortic Coarctation | 2 | 2017 | 110 | 0.620 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 59 | 0.620 |
Why?
|
| Foramen Ovale, Patent | 1 | 2019 | 19 | 0.610 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2016 | 19 | 0.600 |
Why?
|
| Hypoxia | 1 | 2020 | 262 | 0.600 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 164 | 0.590 |
Why?
|
| Heart Diseases | 2 | 2013 | 522 | 0.560 |
Why?
|
| Aortic Diseases | 1 | 2020 | 202 | 0.560 |
Why?
|
| Transposition of Great Vessels | 2 | 2017 | 133 | 0.550 |
Why?
|
| Hypertension, Pulmonary | 4 | 2017 | 467 | 0.540 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 1159 | 0.540 |
Why?
|
| Norwood Procedures | 1 | 2017 | 104 | 0.510 |
Why?
|
| Bioprosthesis | 1 | 2017 | 117 | 0.510 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 211 | 0.490 |
Why?
|
| Heart Failure | 5 | 2022 | 2417 | 0.480 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 346 | 0.480 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 63 | 0.480 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 148 | 0.470 |
Why?
|
| Arterial Switch Operation | 1 | 2015 | 24 | 0.470 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2015 | 29 | 0.470 |
Why?
|
| Cardiology Service, Hospital | 1 | 2014 | 15 | 0.440 |
Why?
|
| Behcet Syndrome | 1 | 2014 | 19 | 0.440 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 33 | 0.430 |
Why?
|
| Hospitals, Pediatric | 3 | 2018 | 789 | 0.430 |
Why?
|
| Hemodynamics | 4 | 2020 | 868 | 0.420 |
Why?
|
| Health Resources | 1 | 2014 | 125 | 0.400 |
Why?
|
| Aneurysm, False | 1 | 2014 | 94 | 0.400 |
Why?
|
| Adult | 22 | 2024 | 31946 | 0.350 |
Why?
|
| Humans | 40 | 2024 | 133932 | 0.350 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 105 | 0.330 |
Why?
|
| Women's Health | 1 | 2011 | 150 | 0.320 |
Why?
|
| Prosthesis Design | 4 | 2019 | 711 | 0.300 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2020 | 257 | 0.280 |
Why?
|
| Female | 24 | 2024 | 71659 | 0.250 |
Why?
|
| Fontan Procedure | 3 | 2019 | 191 | 0.230 |
Why?
|
| Retrospective Studies | 13 | 2024 | 17481 | 0.220 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2024 | 224 | 0.220 |
Why?
|
| Young Adult | 10 | 2018 | 9887 | 0.200 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 64 | 0.200 |
Why?
|
| Ventricular Function, Left | 2 | 2017 | 544 | 0.190 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2018 | 640 | 0.180 |
Why?
|
| Child | 8 | 2022 | 25739 | 0.180 |
Why?
|
| Hospital Mortality | 4 | 2017 | 1087 | 0.180 |
Why?
|
| Adolescent | 12 | 2019 | 20536 | 0.180 |
Why?
|
| Hope | 1 | 2020 | 15 | 0.160 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2017 | 22 | 0.160 |
Why?
|
| Solutions | 1 | 2019 | 67 | 0.160 |
Why?
|
| Anticoagulants | 3 | 2022 | 598 | 0.160 |
Why?
|
| Off-Label Use | 1 | 2019 | 28 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 190 | 0.150 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2019 | 122 | 0.150 |
Why?
|
| Atrial Fibrillation | 2 | 2024 | 684 | 0.140 |
Why?
|
| Male | 17 | 2024 | 65882 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 122 | 0.140 |
Why?
|
| Syndrome | 1 | 2020 | 1165 | 0.140 |
Why?
|
| Time Factors | 6 | 2024 | 6588 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2018 | 91 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 209 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 129 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 205 | 0.130 |
Why?
|
| Heterografts | 1 | 2017 | 199 | 0.130 |
Why?
|
| Vascular Access Devices | 1 | 2016 | 36 | 0.130 |
Why?
|
| Ductus Arteriosus | 1 | 2017 | 62 | 0.130 |
Why?
|
| Vena Cava, Superior | 1 | 2016 | 60 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 34 | 0.130 |
Why?
|
| Femoral Artery | 1 | 2016 | 191 | 0.120 |
Why?
|
| Heart Transplantation | 1 | 2022 | 894 | 0.120 |
Why?
|
| Executive Function | 1 | 2016 | 125 | 0.120 |
Why?
|
| Middle Aged | 9 | 2023 | 29394 | 0.120 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 331 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 149 | 0.120 |
Why?
|
| Heart Arrest | 1 | 2019 | 376 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 2015 | 99 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2017 | 3226 | 0.110 |
Why?
|
| Thoracotomy | 1 | 2015 | 113 | 0.110 |
Why?
|
| Pulmonary Circulation | 1 | 2015 | 122 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 177 | 0.110 |
Why?
|
| Survivors | 1 | 2016 | 360 | 0.110 |
Why?
|
| Aorta | 1 | 2017 | 561 | 0.110 |
Why?
|
| Electric Countershock | 1 | 2014 | 73 | 0.110 |
Why?
|
| Swine | 1 | 2017 | 1216 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 381 | 0.110 |
Why?
|
| Thrombosis | 1 | 2018 | 537 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2015 | 3695 | 0.100 |
Why?
|
| Risk Factors | 6 | 2018 | 11087 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2015 | 1002 | 0.100 |
Why?
|
| Stroke | 1 | 2022 | 1073 | 0.100 |
Why?
|
| Pulmonary Veins | 1 | 2015 | 166 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2014 | 158 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2017 | 566 | 0.100 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 291 | 0.100 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 267 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 478 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 311 | 0.100 |
Why?
|
| Survival Rate | 2 | 2018 | 2207 | 0.090 |
Why?
|
| Echocardiography | 1 | 2018 | 1124 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 2295 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 290 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1315 | 0.090 |
Why?
|
| Cognition | 1 | 2016 | 815 | 0.090 |
Why?
|
| Infant | 4 | 2019 | 13161 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2014 | 412 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 134 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2014 | 571 | 0.080 |
Why?
|
| Age Factors | 2 | 2014 | 2977 | 0.080 |
Why?
|
| Patient Admission | 1 | 2011 | 190 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 3072 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 548 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5505 | 0.080 |
Why?
|
| Disease Management | 1 | 2013 | 560 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 514 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1871 | 0.070 |
Why?
|
| Texas | 2 | 2014 | 3689 | 0.070 |
Why?
|
| Incidence | 2 | 2018 | 3393 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2022 | 730 | 0.070 |
Why?
|
| United States | 5 | 2018 | 11683 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 678 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 1150 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3476 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 2239 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1407 | 0.050 |
Why?
|
| Amiodarone | 1 | 2024 | 46 | 0.050 |
Why?
|
| Hospitalization | 1 | 2012 | 1887 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1334 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2019 | 8592 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 63 | 0.050 |
Why?
|
| Pregnancy | 2 | 2014 | 7523 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2019 | 14800 | 0.050 |
Why?
|
| Heart Rate | 1 | 2024 | 600 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 5074 | 0.040 |
Why?
|
| Aged | 3 | 2014 | 21730 | 0.040 |
Why?
|
| Warfarin | 1 | 2022 | 124 | 0.040 |
Why?
|
| Prevalence | 3 | 2012 | 2654 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1489 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 507 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2017 | 131 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 141 | 0.030 |
Why?
|
| Phlebography | 1 | 2016 | 45 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 204 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 1615 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 113 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 88 | 0.030 |
Why?
|
| Length of Stay | 2 | 2012 | 1383 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 183 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 384 | 0.030 |
Why?
|
| Animals | 1 | 2017 | 36398 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2016 | 186 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1189 | 0.030 |
Why?
|
| Attention | 1 | 2016 | 208 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 474 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1124 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 983 | 0.020 |
Why?
|
| Registries | 1 | 2019 | 1563 | 0.020 |
Why?
|
| Phenylpropionates | 1 | 2011 | 3 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 867 | 0.020 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2011 | 15 | 0.020 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2011 | 37 | 0.020 |
Why?
|
| Epoprostenol | 1 | 2011 | 71 | 0.020 |
Why?
|
| Heart Atria | 1 | 2014 | 333 | 0.020 |
Why?
|
| Pyridazines | 1 | 2011 | 54 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2016 | 799 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 722 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 559 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2807 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2011 | 286 | 0.020 |
Why?
|
| Transition to Adult Care | 1 | 2011 | 119 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1337 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3640 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 409 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 1006 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2011 | 230 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 3739 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2940 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5173 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 1735 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 6664 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 934 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3849 | 0.010 |
Why?
|